Related Experiment Video

Updated: May 30, 2026

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

Can we predict who's at risk for developing bone metastases in breast cancer?

Larissa A Korde, Julie R Gralow

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |August 24, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
    07:35

    A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

    Published on: December 26, 2016

    Models of Bone Metastasis
    08:49

    Models of Bone Metastasis

    Published on: September 4, 2012

    Related Experiment Videos

    Last Updated: May 30, 2026

    Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
    07:00

    Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

    Published on: September 26, 2016

    A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
    07:35

    A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

    Published on: December 26, 2016

    Models of Bone Metastasis
    08:49

    Models of Bone Metastasis

    Published on: September 4, 2012

    Related Concept Videos

    Metastasis02:30

    Metastasis

    Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
    Epithelial-to-Mesenchymal Transition
    The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

    Articles linked to this work by shared authors, journal, and citation graph.

    Recurrence Score® gene group components and outcomes in the RxPONDER trial (SWOG S1007).

    Journal of the National Cancer Institute·2026

    Updated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer.

    JNCI cancer spectrum·2026

    The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial.

    JAMA oncology·2025

    The Oncology Drug Shortage: ASCO's Vision and Proposals for Resolving This Public Health Emergency.

    Cancer journal (Sudbury, Mass.)·2025

    Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Metabolic dynamic score and machine learning: a novel approach to predicting pathological complete response in rectal cancer after neoadjuvant chemoradiotherapy.

    Frontiers in oncology·2026

    Association of alkalization therapy with long-term survival in stage IV or recurrent colorectal cancer: interaction with RAS mutation status.

    Frontiers in oncology·2026

    Association of postoperative delayed bowel function recovery with weight and muscle loss at 6 months in colorectal cancer patients.

    Frontiers in nutrition·2026

    Study on the expression of p53, PTEN, and p16 in endometrial polyps of breast cancer patients receiving endocrine therapy: a comparative study of immunohistochemistry.

    Frontiers in oncology·2026

    Prevalence and clinical impact of PIK3CA and PTEN alterations from reflex genomic testing of newly diagnosed colorectal cancer: a population-based series.

    Frontiers in oncology·2026

    Automated classification of osteoporotic vertebral compression fractures in DR images based on improved YOLO26n-seg.

    Frontiers in medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us